Compile Data Set for Download or QSAR
Report error Found 37 Enz. Inhib. hit(s) with Target = 'Erythropoietin receptor'
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463576(CHEMBL4249192)
Affinity DataEC50:  42nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463567(CHEMBL4240318)
Affinity DataEC50:  540nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463568(CHEMBL4246983)
Affinity DataEC50:  240nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463569(CHEMBL4243291)
Affinity DataEC50:  26nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463570(CHEMBL4243549)
Affinity DataEC50:  31nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463571(CHEMBL4244160)
Affinity DataEC50:  540nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463572(CHEMBL4244951)
Affinity DataEC50:  540nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463573(CHEMBL4239773)
Affinity DataEC50:  12nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463574(CHEMBL4239220)
Affinity DataEC50:  31nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50463575(CHEMBL4244759)
Affinity DataEC50:  11nMAssay Description:Agonist activity at EPO receptor in human TF1 cells assessed as induction of cell proliferation after 48 hrs by MTT assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091849(4-{(R)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-[2-(2-...)
Affinity DataIC50: 1.50E+3nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091861(N-{(R)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-[2-(2-...)
Affinity DataIC50: 1.50E+3nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091841((S)-6-Amino-2-[bis-(4-benzyloxy-benzyl)-amino]-hex...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091862(4-{(S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-[3-(4-...)
Affinity DataIC50: 4.00E+3nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091858(GGQPK-cyclic-(CVWTLPGFHC)-YSTGG-NH2 | CHEMBL440818)
Affinity DataIC50: 5.00E+3nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091854(N-{(S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-[3-(4-...)
Affinity DataIC50: 6.00E+3nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091850(N-((S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-{3-[2-...)
Affinity DataIC50: 7.00E+3nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091855((S)-6-Amino-2-[bis-(3-benzyloxy-benzyl)-amino]-hex...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091851((S)-6-Amino-2-((3-benzyloxy-benzyl)-{(E)-3-[3-(4-t...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091840(4-((S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-{3-[2-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091843((S)-6-Amino-2-[bis-(4-benzyloxy-benzyl)-amino]-hex...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091837((R)-3-[Bis-(4-benzyloxy-benzyl)-amino]-N-{3-[4-(3-...)
Affinity DataIC50: 1.80E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091838((S)-3-[Bis-(4-benzyloxy-benzyl)-amino]-N-(3-{2-[2-...)
Affinity DataIC50: 2.80E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091846((S)-6-Amino-2-{(3-phenoxy-benzyl)-[(E)-3-(3-phenox...)
Affinity DataIC50: 3.00E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091844((S)-2-(Bis-{(E)-3-[3-(4-tert-butyl-phenoxy)-phenyl...)
Affinity DataIC50: 3.00E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091857((S)-2-{Bis-[(E)-3-(3-phenoxy-phenyl)-allyl]-amino}...)
Affinity DataIC50: 3.50E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091859((S)-2-(Bis-{(E)-3-[3-(3-trifluoromethyl-phenoxy)-p...)
Affinity DataIC50: 3.50E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091842((S)-2-{Bis-[(E)-3-(3-phenoxy-phenyl)-allyl]-amino}...)
Affinity DataIC50: 3.50E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091856((S)-2-{Bis-[(E)-3-(3-phenoxy-phenyl)-allyl]-amino}...)
Affinity DataIC50: 3.60E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091860((S)-2-{(3-Phenoxy-benzyl)-[(E)-3-(3-phenoxy-phenyl...)
Affinity DataIC50: 4.00E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091839((S)-2-{Bis-[(E)-3-(3-phenoxy-phenyl)-allyl]-amino}...)
Affinity DataIC50: 4.00E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091836((S)-2-{Bis-[(E)-3-(3-phenoxy-phenyl)-allyl]-amino}...)
Affinity DataIC50: 4.20E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091845((S)-4-[Bis-(4-benzyloxy-benzyl)-amino]-4-{2-[2-(2-...)
Affinity DataIC50: 7.50E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091847(4-((S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-{12-[(...)
Affinity DataIC50: 8.50E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091848({Bis-[(E)-3-(3-phenoxy-phenyl)-allyl]-amino}-aceti...)
Affinity DataIC50: 8.50E+4nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091852(N-((S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-{12-[(...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetErythropoietin receptor(Human)
Beijing Institute of Pharmacology and Toxicology

Curated by ChEMBL
LigandPNGBDBM50091853((S)-2-{Bis-[(E)-3-(3-phenoxy-phenyl)-allyl]-amino}...)
Affinity DataIC50: 1.45E+5nMAssay Description:Compound was evaluated for inhibition of [125I]EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed